Adaptimmune Therapeutics PLC ADAP Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	328.92M	288.08M	342.98M	296.64M	282.62M	258.01M	321.7M	317.44M
Total Current Assets	255.37M	213.75M	261.77M	219.37M	207.55M	186.9M	253.77M	244.21M
Cash and Equivalents	108.03M	119.87M	76.97M	90.06M	143.99M	140.67M	211.81M	116.74M
Total Non-Current Assets	55.53M	110.75M	136.71M	129.84M	105.25M	99.96M	113.8M	118.02M
Total Liabilities	247.04M	204.21M	216.33M	208.51M	243.1M	233.64M	225.43M	237.45M
Total Current Liabilities	64.5M	63.63M	76.13M	75.15M	72.79M	66.41M	82.07M	63.46M
Total Non-Current Liabilities	182.54M	140.57M	140.21M	133.36M	170.32M	167.22M	168.31M	223.86M
Common Equity	1.4M	1.41M	1.85M	1.86M	1.87M	2.08M	2.08M	2.08M
Retained Earnings	-909.3M	-908.27M	-929.66M	-975.26M	-1.02B	-1.07B	-1B	-1.02B

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	239.14M	287.21M	282.95M	181.54M	451.14M	469.55M	328.92M	282.62M
Total Current Assets	198.75M	230.18M	231.1M	120.49M	398.15M	415.46M	255.37M	207.55M
Cash and Equivalents	158.78M	84.04M	68.38M	50.41M	56.88M	149.95M	108.03M	143.99M
Total Non-Current Assets	170.77M	209.05M	253.1M	123.64M	341.23M	205.96M	81.88M	39.51M
Total Liabilities	68.37M	78.16M	29.85M	57.91M	109.92M	263.59M	247.04M	243.1M
Total Current Liabilities	40.27M	74.31M	24.44M	34.34M	39.07M	62.54M	64.5M	72.79M
Total Non-Current Liabilities	28.1M	3.85M	5.41M	46.53M	70.84M	201.04M	182.54M	170.32M
Total Equity	170.77M	209.05M	253.1M	123.64M	341.23M	205.96M	81.88M	39.51M
Common Equity	683k	854k	939k	943k	1.33M	1.34M	1.4M	1.87M
Retained Earnings	-114.81M	-176.76M	-243.72M	-455.66M	-585.76M	-743.85M	-909.3M	-1.02B